COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,789 Articles (22,946 medRxiv, 8,843 bioRxiv)

Most recent first Previous |  Page 362: Articles 3611-3620  | Next

The SARS-CoV-2 Omicron sub-variant BA.2.86 is attenuated in hamsters
Herder, V., Mendonca, D. C., Upfold, N., Furnon, W., Kerr, K., Ilia, G., Allan, J., Sigal, A., Patel, A. H., Palmarini, M.
10.1101/2023.11.10.566576 — Posted: 2023-11-12
Insights into B Cell and Antibody Kinetics Against SARS-CoV-2 Variants Using Mathematical Modelling
Farhang-Sardroodi, S., Deng, X., Portet, S., Arino, J., Craig, M.
10.1101/2023.11.10.566587 — Posted: 2023-11-12
Clinical and Economic impact of updated Fall 2023 COVID-19 vaccines in the Immunocompromised Population in Canada
Lee, A., Jayasundara, K., Kohli, M., Maschio, M., Fust, K., Joshi, K., Van de Velde, N., Beck, E.
10.1101/2023.11.10.23298369 — Posted: 2023-11-11
Importations of SARS-CoV-2 lineages decline after nonpharmaceutical interventions in phylogeographic analyses
Goliaei, S., Foroughmand-Araabi, M.-H., Roddy, A., Weber, A., Oeversti, S., Kuehnert, D., McHardy, A. C.
10.1101/2023.11.10.23298337 — Posted: 2023-11-10
Topic: Effect of Lockdown Of COVID-19 And The Impact On People Living In Enugu State, Nigeria
Ojielo, N. C., Onwuliri, D. C., Onuh, A., Ilo, A., Njeze, N. R.
10.1101/2023.11.10.23298376 — Posted: 2023-11-10
Generation and characterization of a multi-functional panel of monoclonal antibodies for SARS-CoV-2 research and treatment
Patterson, L. D., Dubansky, B. D., Dubansky, B. H., Stone, S., Kumar, M., Rice, C. D.
10.1101/2023.11.08.566276 — Posted: 2023-11-10
Effectiveness of non-pharmaceutical interventions on SARS-CoV-2 transmission during the period January 2021 until May 2022: A systematic literature review
Vardavas, C. I., Nikitara, K., Aslanoglou, K., Marou, V., Plyta, Z., Phalkey, R., Leonardi Bee, J., Condell, O., Lamb, F., Suk, J. E.
10.1101/2023.11.10.23298350 — Posted: 2023-11-10
One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
Leavy, O. C., Russell, R. J., Harrison, E. M., Lone, N. I., Kerr, S., Docherty, A. B., Sheikh, A., Richardson, M., Elneima, O., Greening, N. J., Harris, V. C., Houchen-Wolloff, L., McAuley, H. J. C., Saunders, R. M., Sereno, M., Shikotra, A., Singapuri, A., Aul, R., Beirne, P., Bolton, C. E., Brown, J. S., Choudhury, G., Diar Bakerly, N., Easom, N., Echevarria, C., Fuld, J., Hart, N., Hurst, J. R., Jones, M., Parekh, D., Pfeffer, P., Rahman, N. M., Rowland-Jones, S., Shah, A. M., Wootton, D. G., Jolley, C., Thompson, A. R., Chalder, T., Davies, M. J., De Soyza, A., Geddes, J. R., Greenhalf, W.
10.1101/2023.11.09.23298162 — Posted: 2023-11-10
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases
Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., Carreras-Martinez, J. J., Correcher-Martinez, E., Urchueguia-Fornes, A., Martin-Perez, M., Garcia-Poza, P., Villalobos, F., Palleja-Millan, M., Bissacco, C. A., Segundo, E., Souverein, P., Riefolo, F., Duran, C. E., Gini, R., Sturkenboom, M., Klungel, O., Douglas, I.
10.1101/2023.11.10.23298290 — Posted: 2023-11-10
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: implications for bone health
Barclay, N. L., Catala, M., Jodicke, A. M., Prieto-Alhambra, D., Newby, D., Delmestri, A., Man, W. Y., Rosello Serrano, A., Pineda-Moncusi, M., The OPTIMA Consortium
10.1101/2023.11.09.23298305 — Posted: 2023-11-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).